v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
May 31, 2026
May 31, 2025
Feb. 28, 2026
Cash (used) provided by operating activities:      
Net income (loss) $ 35,762 $ (450,718)  
Adjustments to reconcile net income (loss) to net cash (used) provided by operating activities:      
Depreciation and amortization 13,377 14,084  
Amortization of financing costs 406 369  
Non-cash operating lease expense 3,344 2,189  
Provision for credit losses 1,198 621  
Non-cash share-based compensation 6,437 296  
Asset impairment charges 0 414,385  
Gain on sale of distribution facility  (54,854) 0  
Gain on the sale or disposal of property and equipment (32) (39)  
Deferred income taxes and tax credits 4,346 (19,988)  
Changes in operating capital, net of effects of acquisition of business:      
Receivables 34,405 114,092  
Inventory (11,583) (31,512)  
Prepaid expenses and other current assets (9,132) (1,777)  
Other assets and liabilities, net 84 (271)  
Accounts payable (7,555) (42,372)  
Accrued expenses and other current liabilities (11,248) 15,019  
Accrued income taxes (5,591) 43,960  
Net cash (used) provided by operating activities (636) 58,338  
Cash provided (used) by investing activities:      
Capital and intangible asset expenditures (5,806) (13,362)  
Net proceeds from business acquired 0 3,880  
Payments for purchases of U.S. Treasury Bills (724) (687)  
Proceeds from maturities of U.S. Treasury Bills 657 639  
Proceeds from sale of distribution facility 78,160 0  
Proceeds from the sale of property and equipment 32 46  
Proceeds from promissory note 164 0  
Net cash provided (used) by investing activities 72,483 (9,484)  
Cash used by financing activities:      
Proceeds from revolving loans 257,740 131,500  
Repayment of revolving loans (316,560) (424,200)  
Proceeds from term loans 0 250,000  
Repayment of long-term debt (6,250) (2,344)  
Payment of financing costs 0 (434)  
Payment for contingent consideration (4,100) 0  
Proceeds from share issuances under share-based compensation plans 1,334 1,757  
Payments for repurchases of common stock (1,215) (1,331)  
Net cash used by financing activities (69,051) (45,052)  
Net increase in cash and cash equivalents 2,796 3,802  
Cash and cash equivalents, beginning balance 18,886 18,867 $ 18,867
Cash and cash equivalents, ending balance 21,682 22,669 $ 18,886
Supplemental non-cash investing activity:      
Capital expenditures included in accounts payable and accrued expenses $ 6,380 $ 6,670